Sialis 5 mg 14 tablets
Cerebrolysin 5 ml 5 vials
Prednisolone 5mg 100 tablets
Hypoxen 250 mg 30 capsules
Sildenafil 100 mg 20 tablets
Tamiflu 75 mg 10 capsules
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
Avodart 0,5 mg 90 capsules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
Piracetam 800 mg 30 tablets
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Champix 1 mg 112 tablets
Actovegin 5 ml 5 vials
tagista 16 mg 30 tablets
Mexidol 5 ml 5 vials
Memoplant 80 mg 30 tablets
Persen 60 tablets
Picamilon 50 mg 30 tablets
Teraligen 5 mg 25 tablets
Vinpocetine 5 mg 50 tablets
Actovegin 200 mg 50 tablets
Midantan 100 mg 100 tablets
Sermion 10 mg 50 tablets
Deprim 30 tablets
encephabol 100 mg 50 tablets
Stugeron 25mg 50 tablets
Ceraxon 1000 mg/4 ml 5 vials
Betahistine 16 mg 30 tablets
Donormil 30 tablets
Combilipen 30 tablets
Lamolep 50 mg 30 tablets
Mexidol 2 ml 10 vials
VIFERON-3 1000000ME 10 suppositories
Manufacturer: Feron
Country of origin: Russia
General description: Cytokine
Pharmacological action
Interferon alfa-2b human recombinant possesses antiviral, immunomodulatory, antiproliferative properties, suppresses the replication of RNA and DNA-containing viruses. Immunomodulatory properties of interferon alfa-2b, such as an increase in the phagocytic activity of macrophages, an increase in the specific cytotoxicity of lymphocytes to target cells, cause its mediated antibacterial activity.
In the presence of ascorbic acid and alpha-tocopherol acetate, the specific antiviral activity of interferon alfa-2b increases, its immunomodulating effect increases, which allows increasing the efficiency of the organism's own immune response to pathogenic microorganisms. When using the drug, the level of secretory immunoglobulins class A increases, the level of immunoglobulin E normalizes, and the endogenous system of interferon alfa-2b is restored. Ascorbic acid and alpha-tocopherol acetate, being highly active antioxidants, have anti-inflammatory, membrane-stabilizing, and regenerating properties. It was found that when Viferon® is used, there are no side effects arising from the parenteral administration of interferon alfa-2b preparations, antibodies that neutralize the antiviral activity of interferon alfa-2b are not formed. The use of the drug Viferon ® as a part of complex therapy allows to reduce therapeutic doses of antibacterial and hormonal drugs, as well as to reduce the toxic effects of this therapy.
Cocoa butter contains phospholipids, which make it possible not to use synthetic toxic emulsifiers in production, and the presence of polyunsaturated fatty acids facilitates the introduction and dissolution of the drug.
Indications
- Acute respiratory viral infections, including influenza, incl. complicated by bacterial infection, pneumonia (bacterial, viral, chlamydial) in children and adults as part of complex therapy;
Infectious and inflammatory diseases of newborn children, incl. premature, such as meningitis (bacterial, viral), sepsis, intrauterine infection (chlamydia, herpes, cytomegalovirus infection, enterovirus infection, candidiasis, including visceral, mycoplasmosis), as part of complex therapy;
- chronic viral hepatitis B, C, D in children and adults as part of complex therapy, incl. in combination with the use of plasmapheresis and hemosorption in chronic viral hepatitis of severe activity complicated by cirrhosis of the liver;
- Infectious-inflammatory diseases of the urogenital tract (chlamydia, cytomegalovirus infection, ureaplasmosis, trichomoniasis, gardnerellez, papillomavirus infection, bacterial vaginosis, recurrent vaginal candidiasis, mycoplasmosis) in adults as part of complex therapy;
- primary or recurrent herpetic infection of the skin and mucous membranes, localized form, mild and moderate-to-moderate flow, incl. urogenital form in adults.


.